Notice: Prescription Drug List (PDL): Hyoscine butylbromide

August 26, 2016
Our file number: 16-109536-761

The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by adding it to the Human Prescription Drug List (PDL). Injectable Hyoscine butylbromide is already listed on the Veterinary Prescription Drug List. Health Canada has conducted a scientific review of Hyoscine butylbromide against a set of established and publicly available criteria outlined in section C.01.040.3 of the Food and Drug Regulations. The listing now reads:

Drugs containing the following: Hyoscine butylbromide

Qualifier: when recommended for parenteral use

Effective Date: date of this Notice

Should you have any questions on this update to the Prescription Drug List, please contact:

Prescription Drug Status Committee
Health Canada
Holland Cross, Tower B, 2nd Floor
1600 Scott Street
Address Locator 3102C3
Ottawa, Ontario
K1A 0K9

Email: drug prescription status
Phone: 613-957-1058
Fax: 613-941-1812

Page details

Date modified: